Return of polygenic risk scores in research: Stakeholders’ views on the eMERGE-IV study by Maya Sabatello, Suzanne Bakken, Wendy K. Chung, Elizabeth Cohn, Katherine D. Crew, Krzysztof Kiryluk, Rita Kukafka, Chunhua Weng, Paul S. Appelbaum

Get full text

Prevalence and incidence measures for schizophrenia among commercial health insurance and medicaid enrollees by Molly T. Finnerty, Atif Khan, Kai You, Rui Wang, Gyojeong Gu, Deborah Layman, Qingxian Chen, Noémie Elhadad, Shalmali Joshi, Paul S. Appelbaum, Todd Lencz, Sander Markx, Steven A. Kushner, Andrey Rzhetsky

Get full text

Postsurgical morbidity and mortality favorably informs deep brain stimulation for new indications including schizophrenia and schizoaffective disorder by Judith M. Gault, Judith M. Gault, Patrick Hosokawa, Daniel Kramer, Elyn R. Saks, Paul S. Appelbaum, John A. Thompson, Ann Olincy, Nicola Cascella, Akira Sawa, Wayne Goodman, Nidal Moukaddam, Sameer A. Sheth, William S. Anderson, Rachel A. Davis, Rachel A. Davis

Get full text